Analysis of the effect of the accelerated approval process for antitumor drugs in the United States and its implications for ChinaZHANG Shuo, JIN Si-yu, YANG Li521-530
Analysis of drug registrations included in the priority review and approval procedure in ChinaZHOU Peng, REN Si-ning, LIU Yuan, HUANG Zhe534-542
Research on the preapproval inspections of FDA and the enlightenment to ChinaZHOU Meng-meng, WANG Bao-feng543-548
Evaluation of immunogenicity of recombinant human serum albumin in cynomolgusPAN Dong-sheng, YANG Shu-han, LIU Li, YU Min, WANG Xiao-xia, LI Qian-qian, LI Bo, ZHOU Xiao-bing549-555
Study on classification of water for pharmaceutical in different countriesZHENG Jie, WU Zhao-wei, AN Jing-ye, ZHU Xiao-yue, WU Bin, ZHANG Zhe, HU Qin, WANG Lin564-568
Examination of factors that influence the release of 3D printed drugsXU Hang-jun, FEI Yun-xuan, GAO Han-yi, LI Ya-nan, XIONG You-xiang, ZHU Zhi-hong569-573
Intelligent management of whole process of lymphoma drug clinical researchJIANG Min, FU Zhi-ying, ZHAO Shu-hua, YUAN Yan-nan, LIU Xiao-hong574-579
Preparation of nanoparticles co-modified with chitosan and cell-penetrating peptides and in vitro cytological evaluation against colon cancerZHAO Yue-qi, LUO Zi-han, ZHONG Hai-jun, XIONG Yuan-zhen, FANG Chuan-zhou, DENG Guo-xing, CHEN Liang, TONG Fei, GUO Feng580-587